Skip to main content
Rural reproductive health in Texas

U.S. Supreme Court takes up Texas case challenging abortion pill access

A majority of Supreme Court justices seemed open to keeping mifepristone, a common abortion-inducing drug, on the market despite a Texas ruling revoking its FDA approval.

People visit the Supreme Court in Washington, D.C. on March 10, 2022.

The next frontier

Timeline of the case

Texans need truth. Help us report it.

Support independent Texas news

Become a member. Join today.

Donate now

Explore related story topics

Courts Health care Politics State government